PAI
RGEN icon

Pittenger & Anderson Inc’s Repligen RGEN Stock Holding History

Pittenger & Anderson Inc’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-65
Closed -$9.67K – 460
2024
Q3 		$9.67K Hold
65
– – ﹤0.01% 375
2024
Q2 		$8.19K Hold
65
– – ﹤0.01% 376
2024
Q1 		$12K Hold
65
– – ﹤0.01% 362
2023
Q4 		$11.7K Hold
65
– – ﹤0.01% 361
2023
Q3 		$10.3K Hold
65
– – ﹤0.01% 350
2023
Q2 		$9.2K Buy
65
+11
+20% +$1.76K ﹤0.01% 365
2023
Q1 		$9.09K Buy
54
+28
+108% +$5K ﹤0.01% 360
2022
Q4 		$4.4K Hold
26
– – ﹤0.01% 385
2022
Q3 		$5K Buy
26
+4
+18% +$843 ﹤0.01% 379
2022
Q2 		$4K Hold
22
– – ﹤0.01% 392
2022
Q1 		$4K Hold
22
– – ﹤0.01% 399
2021
Q4 		$6K Hold
22
– – ﹤0.01% 386
2021
Q3 		$6K Buy
22
+5
+29% +$1.28K ﹤0.01% 388
2021
Q2 		$3K Hold
17
– – ﹤0.01% 380
2021
Q1 		$3K Buy
17
+6
+55% +$1.23K ﹤0.01% 367
2020
Q4 		$2K Buy
11
+3
+38% +$546 ﹤0.01% 358
2020
Q3 		$1K Buy
+8
New +$1.14K ﹤0.01% 362

Other funds holding RGEN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Pittenger & Anderson Inc's RGEN Position: Q4 2024 in Review

Pittenger & Anderson Inc sold out of Repligen (RGEN) in Q4 2024, closing a stake of 65 shares — an estimated $9.67K sold.

Pittenger & Anderson Inc first reported a position in RGEN in Q3 2020 and held it in 17 quarters. The position peaked at $12K in Q1 2024. 431 funds tracked by Wall St. Rank hold RGEN as of Q4 2024.

  • Pittenger & Anderson Inc reported no remaining Repligen position as of Q4 2024 after selling out during the quarter.
  • Pittenger & Anderson Inc sold 65 Repligen shares in Q4 2024, an estimated $9.67K.
  • Pittenger & Anderson Inc first reported a position in Repligen in Q3 2020 and held it in 17 quarters.
  • Pittenger & Anderson Inc's Repligen position peaked at $12K in Q1 2024.
  • 431 funds tracked by Wall St. Rank held Repligen as of Q4 2024.

Based on Pittenger & Anderson Inc's 13F filing for Q4 2024, filed 31 Jan 2025.